viewRoyal Mail PLC

Royal Mail has at least one admirer (although even it has slashed its price target)

"We have revised our forecasts and our target price in the wake of the recent profit warning," Barclays Capital said. The broker said there had been "a sizeable cut to our expectations for this year and beyond"

Letter box
Bad news on the doorstep, I couldn't take one more step

Barclays remains one of the few brokers still advocating topping up holdings in Royal Mail PLC (LON:RMG) following the recent profit warning.

Barclays Capital has slashed its price target to 410p from 605p but as that is still above the current price of 348.5p – down 1.3% on the day – it is sticking with its ‘overweight’ rating.

READ: Royal Mail says UK letters volumes and productivity down, shares plunge

The broker is out of step with most brokers, many of which have also slashed their price targets and declined to move to a more bullish position, despite the 150p (or so) fall in the share price since the profit warning.

Liberum Capital Markets stuck with its ‘sell’ recommendation and slashed its target price to 250p.

Citigroup cut its rating on Royal Mail to ‘sell’ from ‘neutral’ with a target price of 300p.

UBS slashed its price target to 354p from 528p and reiterated its ‘neutral’ stance.

HSBC downgraded to ‘hold’ from ‘buy’ after what it called a “productivity bombshell” and slashed its price target to 379p from 552p.

RBC Capital Markets moved to ‘underperform’ from ‘sector perform’ and its price target was chopped to 315p from 500p.

JPMorgan Cazenove lopped almost two quid off its price target, which now stands at 341p.

Barclays said the profit warning had prompted it to make sizeable reductions to its forecasts.

READ: Royal Mail looks like the proverbial falling knife

Quick facts: Royal Mail PLC

Price: 226 GBX

Market: LSE
Market Cap: £2.26 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Primary Health Properties delivering 'impressive dividend track record and...

Proactive Research analyst Ed Stacey says Primary Health Properties (LON:PHP) has an impressive track record of dividend growth, increasing the payment every year since listing in 1997. On top of that he says they've delivered steady capital gains on its portfolio that have translated into...

5 hours, 24 minutes ago

2 min read